HTN Practice Pt2 Flashcards
amlodipine
norvasc -dhp ccb
nifedipine er
procardia - dhp ccb
diltiazem
cardizem - non dhp ccb
aliskiren
tekturna - diirect renin inhibitor
bisoprolol
zebata - cardioselective beta blockers (beta 1)
metoprolol succinate
toprol - cardioselective beta blocker (beta 1)
carvedilol
coreg - alpha/beta blocker (beta 1 and 2, alpha 1)
dhp ccb moa
inhibits calcium ions from entering slow channels of vascular smooth muscle- leading to vasodilation
dhp ccb contraindications
none
dhp ccb adr
peripheral edema, pulmonary edema, hepatotoxicity, thrombocytopenia
dhp ccb ddi
major substrate of CYP3A4
dhp ccb notes
immediate release nifedipine has increased risk of mi and mortality- only er is used, can take up to one week to see bp lowering effects- no electrolyte changes, major substrate of cyp3a4
non dhp ccb moa
inhibits calcium from entering vascular smooth muscle and myocardium, slowing av node/hr
non dhp ccb contraindications
2nd or 3rd degree heart block
non dhp ccb adr
peripheral edema, pulmonary ede3ma, ha, heart failure, heart block, hepatotoxicity